Vitamin D and Improved Breast Cancer-Specific Quality of Life

• Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

  • 2022-01-10
  • Meta-Analysis · n = 1,250
  • The Cochrane database of systematic reviews 2022(1)
  • • Kate E Roberts
    • India T Adsett
    • Kirsty Rickett
    • Sophie M Conroy
    • Mark D Chatfield
    • Natasha E Woodward

  • PubMed: 35005781
  • DOI: 10.1002/14651858.cd013167.pub2

  6 Insights on

  • Improved Breast Cancer-Specific Quality of Life

  • High evidence
  • Clinical

  The evidence was very uncertain for the outcomes of ... BCS-QoL (2 studies, 147 women)

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  not specified in abstract